Stemline Therapeutics Inc (NASDAQ:STML) was mentioned cautiously in an article by Adam Feuerstein of TheStreet. According to to the report, a patient died …
Proteon Therapeutics Inc (NASDAQ:PRTO) investors are wildly disappointed today amid the firm’s Phase 3 sunken ship for its sole drug contender vonapanitase, sending …
Cowen analyst Boris Peaker weighed in on Cascadian Therapeutics Inc (USA) (NASDAQ:CASC) with a few insights after the company announced that following a recent meeting with …
This morning, Idera Pharmaceuticals Inc (NASDAQ:IDRA) announced a licensing and collaboration agreement with Vivelix for rights to develop and market IMO-9200, a TLR …
With near-term financing overhang removed and more confident in Iluvien’s sales growth, Cowen analyst Boris Peaker upgrades shares of Alimera Sciences Inc (NASDAQ:ALIM) from Market …
In a research report released Tuesday, Cowen analyst Boris Peaker reiterated a Market Perform rating on shares of Alimera Sciences Inc (NASDAQ:ALIM), with a …
Keryx Biopharmaceuticals (NASDAQ:KERX) just withdrew guidance for 2016 after an interrupted drug supply for its only pipeline drug, Auryxia, a drug created to …
Cowen’s healthcare analyst Boris Peaker weighed in today on biotech firm Heron Therapeutics Inc (NASDAQ:HRTX), following the company’s fourth-quarter financial results and update on its clinical …
Cowen’s healthcare analyst Boris Peaker weighed in today with a few insights on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company provided a regulatory update on Zalviso, which …
Cowen analyst Boris Peaker was out pounding the table on Celldex Therapeutics, Inc. (NASDAQ:CLDX) Tuesday, reiterating an Outperform rating and price target of $28, which …
